Ezetimibe added to on-going statin therapy for treatment of primary hypercholesterolemia: efficacy and safety in patients with Type 2 diabetes mellitus

被引：0
|
作者：
Simons, L
Musliner, T
Quinto, K
Cho, M
Gumbiner, B
机构：
[1] Merck Schering Plough Pharmaceut, N Wales, PA USA
[2] Univ New S Wales, St Vincents Hosp, Lipid Dept, Sydney, NSW, Australia
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1209
引用
收藏
页码：A389 / A389
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of Ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia
    Gagné, C
    Bays, HÉ
    Weiss, SR
    Mata, P
    Quinto, K
    Melino, M
    Cho, M
    Musliner, TA
    Gumbiner, B
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (10): : 1084 - 1091
  • [2] Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome
    Simons, L
    Tonkon, M
    Masana, L
    Maccubbin, D
    Shah, A
    Lee, M
    Gumbiner, B
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) : 1437 - 1445
  • [3] Ezetimibe added to ongoing statin therapy for treatment of primary hypercholesterolemia
    Bays, H
    Weiss, S
    Gagne, C
    Mata, P
    Gumbiner, B
    Melino, M
    Quinto, K
    Cho, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 245A - 245A
  • [4] Effects of ezetimibe added to on-going statin therapy on LDL-C goal attainment in high risk hypercholesterolemic patients with or without type 2 diabetes mellitus
    Simons, L
    Tonkon, M
    Shah, A
    Maccubbin, D
    Gumbiner, B
    DIABETES, 2003, 52 : A133 - A133
  • [5] Effects of ezetimibe added to on-going statin therapy on LDL-C goal attainment in high risk hypercholesterolemic patients with or without Type 2 diabetes mellitus
    Simons, L
    Masana, L
    Tonkon, M
    Shah, A
    Maccubbin, D
    Gumbiner, B
    DIABETOLOGIA, 2003, 46 : A354 - A354
  • [6] The efficacy of Ezetimibe added to ongoing Fibrate-Statin therapy on postprandial lipid profile in the patients with type 2 Diabetes mellitus
    Sharifi F.
    Hojeghani N.
    Mazloomzadeh S.
    Shajari Z.
    Journal of Diabetes & Metabolic Disorders, 12 (1):
  • [7] Effects of ezetimibe added-to on-going statin therapy on the lipid profile of hypercholesterolemic patients with metabolic syndrome
    Tonkon, M
    Simons, L
    Lee, M
    MacCubbin, D
    Gumbiner, B
    DIABETES, 2003, 52 : A214 - A214
  • [8] Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with metabolic syndrome.
    Masana, L
    Tonkon, M
    Simons, L
    Lee, M
    Maccubbin, D
    Gumbiner, B
    DIABETOLOGIA, 2003, 46 : A75 - A75
  • [9] Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy
    Gonzalez, Carlos A.
    Rubio-Guerra, Alberto F.
    Pavia, Abel
    Redding, Francisco J.
    Cervantes, Jose L.
    Zacarias, Jose L.
    Yza, Ruben
    Carranza, Jaime
    Fernandez, Pedro
    Morales, Enrique
    Robles, Francisco J.
    Leyva, Jose L.
    Rodriguez, Leticia
    CLINICAL DRUG INVESTIGATION, 2007, 27 (05) : 333 - 337
  • [10] Effectiveness and Safety of Ezetimibe Added to Statin Therapy in Patients with Primary Dyslipidaemia not Achieving the LDL- C Treatment Goal on Statin Monotherapy
    Carlos A. González
    Alberto F. Rubio-Guerra
    Abel Pavía
    Francisco J. Redding
    José L. Cervantes
    José L. Zacarías
    Rubén Yza
    Jaime Carranza
    Pedro Fernández
    Enrique Morales
    Francisco J. Robles
    José L. Leyva
    Leticia Rodríguez
    Clinical Drug Investigation, 2007, 27 : 333 - 337
12345